28.JPG)
The Nuclear Pharmacy Market Size is valued at USD 6.27 Bn in 2024 and is predicted to reach USD 17.96 Bn by the year 2034 at a 11.2% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
The preparation, dispensing, and management of radioactive materials used in nuclear medicine operations are the focus of nuclear pharmacy, a subspecialty of pharmacy. Small quantities of radioactive substances (radiopharmaceuticals) are used in the medical speciality known as nuclear medicine to diagnose and treat various illnesses and ailments.
The need for radiopharmaceuticals was driven by the rising use of nuclear medicine procedures for diagnostic and therapeutic applications, which fueled the expansion of the nuclear pharmacy business. The need for radiopharmaceuticals was driven by the rising use of nuclear medicine procedures for diagnostic and therapeutic applications, which fueled the expansion of the nuclear pharmacy business.
However, the pandemic impacted the research and development of new radiopharmaceuticals and nuclear medical applications. The rate of innovation in the nuclear pharmacy sector may have been slowed down by limitations on research activities and the allocation of resources to the pandemic response.
The Nuclear Pharmacy Market is segmented on the basis of type and application. Based on type, the market is segmented as Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals (Tc-99m, I-123, Tl-201, Ga-67, Other SPECT Isotopes), PET Radiopharmaceuticals (F-18, Rb-82, Other PET Isotopes)), Therapeutic Nuclear Medicine (Alpha Emitters(Ra-223), Beta Emitters (I-131, Y-90, Sm-153, Lu-177, Re-186, Other Beta Emitters)), Brachytherapy Isotopes (I-125, Ir-192, Pd-103, Cs-131), Other Brachytherapy Isotopes). The application segment includes Diagnostic Applications (SPECT Applications (Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications), PET Applications (Oncology, Cardiology, Neurology, Other PET Applications)), Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications).
The diagnostic nuclear medicine category is expected to hold a major share of the global Nuclear Pharmacy Market in 2021. Due to factors like effective imaging of patients with numerous types of cancer, new product launches for diagnosing various illnesses, and rising procedural volumes globally, this category is also expected to rise at a significant CAGR. Imaging methods used in nuclear medicine diagnostics include planar imaging, single-photon emission computed tomography (SPECT), and positron emission tomography (PET). Each method offers distinct knowledge about the anatomy, physiology, and molecular functions of the organism.
The diagnostic segment division is projected to grow at a rapid rate in the global Nuclear Pharmacy Market. A wide variety of radiopharmaceuticals used in various diagnostic imaging studies are prepared and compounded by commercial nuclear pharmacies. To assure the safety and effectiveness of radiopharmaceuticals, they are prepared in a controlled setting using stringent quality control procedures. Commercial nuclear pharmacies provide support for a variety of medical imaging modalities, including planar imaging, SPECT (Single-Photon Emission Computed Tomography) and Positron Emission Tomography (PET).
The North American, Nuclear Pharmacy Market, is expected to register the highest market share in terms of revenue in the near future. The region is likely to witness rapid acceptance of technologically advanced and effective medicinal radiopharmaceuticals, as well as an increase in the use of nuclear imaging technology.
In addition, it is anticipated that throughout the projected period, the prevalence of various cancers and other chronic conditions will contribute to the market's rise in North America. As a result of the leading companies' recent product releases and the adoption of cutting-edge radiopharmaceuticals, Europe is predicted to experience significant market expansion. Additionally, this region's market players' acquisitions and mergers are promoting regional expansion.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 6.27 Bn |
|
Revenue forecast in 2034 |
USD 17.96 Bn |
|
Growth rate CAGR |
CAGR of 11.2% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
By Type, By application |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; Japan; India; South Korea; South East Asia |
|
Competitive Landscape |
GE HealthCare, Cardinal Health, Curium, Bayer AG, Lantheus Holdings, Inc., Bracco Imaging S.p.A., PharmaLogic Holdings Corp., Eczacibasi-Monrol Nuclear Products, NTP Radioisotopes SOC Ltd, Nordion Inc., Novartis (Advanced Accelerator Application), NorthStar Medical Radioisotopes, Eckert & Ziegler, Isotope JSC, Siemens Healthineers, Jubilant DraxImage,Inc., Telix Pharmaceuticals Limited, Mallinckrodt Pharmaceuticals, Bracco, IBA Worldwide, Other Prominent Players |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nuclear Pharmacy Market Snapshot
Chapter 4. Global Nuclear Pharmacy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Diagnostic Nuclear Medicine
5.2.1.1. SPECT Radiopharmaceuticals
5.2.1.1.1. Tc-99m
5.2.1.1.2. I-123
5.2.1.1.3. Tl-201
5.2.1.1.4. Ga-67
5.2.1.1.5. Other SPECT Isotopes
5.2.1.2. PET Radiopharmaceuticals
5.2.1.2.1. F-18
5.2.1.2.2. Rb-82
5.2.1.2.3. Other PET Isotopes
5.2.2. Therapeutic Nuclear Medicine
5.2.2.1. Alpha Emitters
5.2.2.1.1. Ra-223
5.2.2.2. Beta Emitters
5.2.2.2.1. I-131
5.2.2.2.2. Y-90
5.2.2.2.3. Sm-153
5.2.2.2.4. Lu-177
5.2.2.2.5. Re-186
5.2.2.2.6. Other Beta Emitters
5.2.3. Brachytherapy Isotopes
5.2.3.1. I-125
5.2.3.2. Ir-192
5.2.3.3. Pd-103
5.2.3.4. Cs-131
5.2.3.5. Other Brachytherapy Isotopes
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Diagnostic Applications
6.2.1.1. SPECT Applications
6.2.1.1.1. Cardiology
6.2.1.1.2. Bone Scans
6.2.1.1.3. Thyroid Applications
6.2.1.1.4. Pulmonary Scans
6.2.1.1.5. Other SPECT Applications
6.2.1.2. PET Applications
6.2.1.2.1. Oncology
6.2.1.2.2. Cardiology
6.2.1.2.3. Neurology
6.2.1.2.4. Other PET Applications
6.2.2. Therapeutic Applications
6.2.2.1. Thyroid Indications
6.2.2.2. Bone Metastasis
6.2.2.3. Lymphoma
6.2.2.4. Endocrine Tumors
6.2.2.5. Other Indications
Chapter 7. Nuclear Pharmacy Market Segmentation 4: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
7.1.2. North America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
7.1.3. North America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034
7.2.2. Europe Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
7.2.3. Europe Nuclear Pharmacy Market revenue (US$ Million) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034
7.3.2. Asia Pacific Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
7.3.3. Asia Pacific Nuclear Pharmacy Market revenue (US$ Million) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034
7.4.2. Latin America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
7.4.3. Latin America Nuclear Pharmacy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034
7.5.2. Middle East & Africa Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
7.5.3. Middle East & Africa Nuclear Pharmacy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1 GE HealthCare
8.2.2 Cardinal Health
8.2.3 Curium
8.2.4 Bayer AG
8.2.5 Lantheus Holdings, Inc.
8.2.6 Bracco Imaging S.p.A.
8.2.7 PharmaLogic Holdings Corp.
8.2.8 Eczacibasi-Monrol Nuclear Products
8.2.9 NTP Radioisotopes SOC Ltd
8.2.10 Nordion Inc.
8.2.11 Novartis (Advanced Accelerator Application)
8.2.12 NorthStar Medical Radioisotopes
8.2.13 Eckert & Ziegler
8.2.14 Isotope JSC
8.2.15 Siemens Healthineers
8.2.16 Jubilant DraxImage,Inc.
8.2.17 Telix Pharmaceuticals Limited
8.2.18 Mallinckrodt Pharmaceuticals
8.2.19 Bracco
8.2.20 IBA Worldwide
8.2.21 Other Prominent Players
Nuclear Pharmacy Market By Type-
Nuclear Pharmacy Market By Application-
Nuclear Pharmacy Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
